ATE333298T1 - Vorrichtung für behandlung eines tumors im zentralen nervensystem - Google Patents

Vorrichtung für behandlung eines tumors im zentralen nervensystem

Info

Publication number: ATE333298T1
Authority: AT; Austria
Prior art keywords: nervous system; central nervous; tumor; treating; tumors
Prior art date: 2002-03-21

Application number

AT03251700T

Other languages

English (en)

Inventor

Rolf W Pfirrmann

Ruediger Stendel

Original Assignee

Geistlich Soehne Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-03-21

Filing date

2003-03-19

Publication date

2006-08-15

2003-03-19 Application filed by Geistlich Soehne Ag filed Critical Geistlich Soehne Ag

2006-08-15 Application granted granted Critical

2006-08-15 Publication of ATE333298T1 publication Critical patent/ATE333298T1/de

Links

210000003169 central nervous system Anatomy 0.000 title abstract 3
206010028980 Neoplasm Diseases 0.000 title abstract 2
210000004738 parenchymal cell Anatomy 0.000 abstract 2
239000003429 antifungal agent Substances 0.000 abstract 1
239000003443 antiviral agent Substances 0.000 abstract 1
230000003115 biocidal effect Effects 0.000 abstract 1
230000000973 chemotherapeutic effect Effects 0.000 abstract 1
230000001024 immunotherapeutic effect Effects 0.000 abstract 1
208000015181 infectious disease Diseases 0.000 abstract 1
239000002207 metabolite Substances 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
238000001690 micro-dialysis Methods 0.000 abstract 1
238000011321 prophylaxis Methods 0.000 abstract 1
AJKIRUJIDFJUKJ-UHFFFAOYSA-N taurolidine Chemical compound C1NS(=O)(=O)CCN1CN1CNS(=O)(=O)CC1 AJKIRUJIDFJUKJ-UHFFFAOYSA-N 0.000 abstract 1
229960004267 taurolidine Drugs 0.000 abstract 1
238000011282 treatment Methods 0.000 abstract 1
230000004614 tumor growth Effects 0.000 abstract 1
230000001790 virustatic effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0021—Catheters; Hollow probes characterised by the form of the tubing
- A61M2025/0042—Microcatheters, cannula or the like having outside diameters around 1 mm or less
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0043—Catheters; Hollow probes characterised by structural features
- A61M2025/0057—Catheters delivering medicament other than through a conventional lumen, e.g. porous walls or hydrogel coatings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/06—Head
- A61M2210/0693—Brain, cerebrum
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/10—Trunk
- A61M2210/1003—Spinal column

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Medical Informatics (AREA)
Anesthesiology (AREA)
Oncology (AREA)
Heart & Thoracic Surgery (AREA)
Dermatology (AREA)
Hematology (AREA)
Neurology (AREA)
Communicable Diseases (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Radiation-Therapy Devices (AREA)
Media Introduction/Drainage Providing Device (AREA)
Medicinal Preparation (AREA)
Steroid Compounds (AREA)

AT03251700T 2002-03-21 2003-03-19 Vorrichtung für behandlung eines tumors im zentralen nervensystem ATE333298T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US36582802P	2002-03-21	2002-03-21

Publications (1)

Publication Number	Publication Date
ATE333298T1 true ATE333298T1 (de)	2006-08-15

Family

ID=28454720

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT03251700T ATE333298T1 (de)	2002-03-21	2003-03-19	Vorrichtung für behandlung eines tumors im zentralen nervensystem

Country Status (6)

Country	Link
EP (1)	EP1346745B1 (de)
JP (1)	JP2004033735A (de)
AT (1)	ATE333298T1 (de)
CA (1)	CA2422623A1 (de)
DE (1)	DE60306828T2 (de)
ES (1)	ES2268286T3 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN100352524C (zh) *	2005-03-04	2007-12-05	浙江大学	一种带有透析膜保护的微透析装置
RU2457794C1 (ru) *	2011-01-12	2012-08-10	Федеральное государственное учреждение "Новосибирский научно-исследовательский институт патологии кровообращения имени академика Е.Н. Мешалкина" Министерства здравоохранения и социального развития Российской Федерации" (ФГУ "ННИИПК им. акад. Е.Н. Мешалкина" Минздравсоцразвития России)	Способ радикального удаления глубинно расположенных глиальных внутримозговых опухолей
RU2561030C1 (ru) *	2014-01-30	2015-08-20	Федеральное государственное бюджетное военное образовательное учреждение высшего профессионального образования Военно-медицинская академия им. С.М. Кирова Министерства обороны Российской Федерации (ВМедА)	Способ интраоперационного выявления наличия и локализации глиальных новообразований головного мозга

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU5545596A (en) *	1995-04-28	1996-11-18	Medtronic, Inc.	Intraparenchymal infusion catheter system
US6030358A (en) *	1997-08-08	2000-02-29	Odland; Rick Matthew	Microcatheter and method for site specific therapy
JP5027369B2 (ja) *	1999-12-06	2012-09-19	ガイストリッヒファーマアーゲー	腫瘍を治療する方法
EP1305074A2 (de) *	2000-07-26	2003-05-02	Medtronic, Inc.	Katheter zur zielspezifische verabreichung von medikamenten

2003
- 2003-03-19 DE DE60306828T patent/DE60306828T2/de not_active Expired - Lifetime
- 2003-03-19 CA CA002422623A patent/CA2422623A1/en not_active Abandoned
- 2003-03-19 EP EP03251700A patent/EP1346745B1/de not_active Expired - Lifetime
- 2003-03-19 ES ES03251700T patent/ES2268286T3/es not_active Expired - Lifetime
- 2003-03-19 AT AT03251700T patent/ATE333298T1/de not_active IP Right Cessation
- 2003-03-20 JP JP2003078705A patent/JP2004033735A/ja active Pending

Also Published As

Publication number	Publication date
JP2004033735A (ja)	2004-02-05
EP1346745A1 (de)	2003-09-24
CA2422623A1 (en)	2003-09-21
EP1346745B1 (de)	2006-07-19
ES2268286T3 (es)	2007-03-16
DE60306828T2 (de)	2007-08-02
DE60306828D1 (de)	2006-08-31

Similar Documents

Publication	Publication Date	Title
ATE207352T1 (de)	2001-11-15	Nicht-allosterische gaba a agonisten zur behandlung von schlafstörungen
EP0641204A4 (de)	1995-08-23	17-ether und thioether von 4-aza-steroiden.
ATE396174T1 (de)	2008-06-15	Hydroxyalkylaminderivate als beta-secretase- inhibitoren und deren verwendung zur behandlung der alzheimerschen krankheit oder ähnlicher krankheiten
DE69924641D1 (de)	2005-05-12	Behandlung von asthma anhand von mek-inhibitoren
ATE375341T1 (de)	2007-10-15	Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
GB0318447D0 (en)	2003-09-10	Therapeutic agents
NZ517616A (en)	2002-12-20	Use of retigabin for treating neuropathic pain
EA200701782A3 (ru)	2008-04-28	Производные азаспироалканов в качестве ингибиторов металлопротеаз
ATE144420T1 (de)	1996-11-15	Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen
ATE350030T1 (de)	2007-01-15	Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
BR0212898A (pt)	2004-10-13	Método de tratamento de infecções do ouvido médio
DE60112766D1 (de)	2005-09-22	Verwendung von derivaten der valproinsäureamide und 2-valproinsäureamid zur behandlung und prävention von schmerzen und/oder kopfschmerzen
EP1098642A4 (de)	2004-08-18	Verfahren zur behandlung von zustanden moduliert durch lactosylceramiden
DE60312736D1 (de)	2007-05-03	1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems
DE60008753D1 (de)	2004-04-08	Verwendung von naaladase inhibitoren zur behandlung von angstzuständen und gedächtnisstörungen
DE602004023762D1 (de)	2009-12-03	Für die behandlung von alzheimer-krankheit und ähnlichen leiden geeignete 1-alkyl-3-thiosubstituierte indol-2-alkinsäuren
DE69631381T2 (de)	2004-10-21	Therapeutische und diagnostische agenzien zur behandlung mikrobieller infektionen
NO20044530L (no)	2004-10-21	Fremgangsmate for behandling av kognitive forstyrrelser
ATE138587T1 (de)	1996-06-15	Einrichtung zur medizinischen behandlung
ATE333298T1 (de)	2006-08-15	Vorrichtung für behandlung eines tumors im zentralen nervensystem
ATE332688T1 (de)	2006-08-15	Verwendung von carbinolen zur behandlung von neuropathischer funktionsstörung
ATE401888T1 (de)	2008-08-15	Verwendung von tigecyclin, allein oder in kombination mit rifampin zur behandlung von osteomyelitis und/oder septischer arthritis
JO3446B1 (ar)	2020-07-05	طريقة لمعالجة الأرق الأولي
ATE464048T1 (de)	2010-04-15	Behandlung von alzheimer-krankheit und verwandten zuständen
ATE209914T1 (de)	2001-12-15	Verwendung von pyridylmethylsulfinyl-1h- benzimidazol derivaten zur behandlung durch helicobacter verursachter erkrankungen

Legal Events

Date	Code	Title	Description
2007-01-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties